Harrier preclinical data

HRR.B (Los Angeles) announced that in vivo data in mice shows activity against a lung tumor xenograft, and two prostate cancer xenografts. The topoisomerase inhibitor was able to reduce tumor size in the three solid tumor xenografts, which generally are nonresponsive to anticancer drugs. ...